Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geovax Labs
(NQ:
GOVX
)
8.350
+2.670 (+47.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Geovax Labs
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
71 Biggest Movers From Yesterday
April 27, 2022
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...
Via
Benzinga
Geovax Labs's Earnings Outlook
April 26, 2022
Geovax Labs (NASDAQ:GOVX) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Geovax Labs...
Via
Benzinga
GeoVax Labs Stock Jumps On US Patent For Malaria Vaccine Candidate
April 26, 2022
Via
Benzinga
Geovax Labs: Q4 Earnings Insights
March 09, 2022
Geovax Labs (NASDAQ:GOVX) reported its Q4 earnings results on Wednesday, March 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Geovax...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 26, 2022
Via
Benzinga
GeoVax Announces Issuance of Malaria Vaccine Patent
April 26, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
GeoVax to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update
April 19, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress
April 12, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 22, 2022
Gainers Palisade Bio (NASDAQ:PALI) stock rose 59.0% to $1.28 during Tuesday's pre-market session. The company's market cap stands at $23.3 million. As per the news...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 01, 2022
On Friday, 111 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Citigroup (...
Via
Benzinga
GeoVax Announces Issuance of Cancer Vaccine Patent
March 22, 2022
IND-Enabling Studies Underway for MVA-VLP-MUC1 Vaccine Candidate
Via
NewMediaWire
GeoVax to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022
March 21, 2022
Presentation to Focus on GEO-CM02 Being Developed as a
Via
NewMediaWire
Exposures
COVID-19
GeoVax to Participate in Maxim Group's 2022 Virtual Growth Conference
March 16, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Labs Retains CATO SMS To Manage Its Mid-Stage COVID-19 Vaccine Trials
March 14, 2022
GeoVax Labs Inc (NASDAQ: GOVX) has engaged CATO SMS to manage its two ongoing Phase 2 trials of its COVID-19 vaccine candidate, GEO-CM04S1. One is testing the...
Via
Benzinga
GeoVax Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials
March 14, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
Data Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows it Produced Robust Antibodies and T cells Against SARS-CoV-2
March 10, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax Reports 2021 Year-End Financial Results and Provides Corporate Update
March 09, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
Earnings Preview For Geovax Labs
March 08, 2022
Geovax Labs (NASDAQ:GOVX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-09. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
GeoVax Announces Key Staff Appointments
March 07, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
GeoVax to Report 2021 Financial Results on Wednesday, March 9, 2022 and Provide Corporate Update
February 23, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Earnings Scheduled For March 9, 2022
March 09, 2022
Companies Reporting Before The Bell • REV Group (NYSE:REVG) is expected to report quarterly earnings at $0.11 per share on revenue of $529.44 million. • Express (...
Via
Benzinga
GeoVax CEO Selected as a Recipient of the 2022 Georgia Titan 100
February 22, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Present at the 2022 BIO CEO & Investor Digital Conference
February 08, 2022
Atlanta, GA - (NewMediaWire) - February 08, 2022 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announced today that...
Via
NewMediaWire
Exposures
COVID-19
GeoVax Announces Closing of $10 Million Private Placement
January 20, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Friday's Intraday Session
January 14, 2022
Gainers ATI Physical Therapy (NYSE:ATIP) stock increased by 22.7% to $3.73 during Friday's regular session. Trading volume for ATI Physical Therapy's stock is 14.3...
Via
Benzinga
GeoVax Announces $10 Million Private Placement
January 14, 2022
Atlanta, GA - (NewMediaWire) - January 14, 2022 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announced today that it...
Via
NewMediaWire
GeoVax Retains CATO SMS To Manage Gedeptin Phase 1/2 Clinical Trial
January 13, 2022
GeoVax Labs, Inc. (NASDAQ: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced the engagement of CATO SMS to...
Via
Benzinga
GeoVax Retains CATO SMS to Manage Gedeptin Phase 1/2 Clinical Trial
January 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax Appoints Dr. Kelly McKee as Chief Medical Officer
January 11, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax to Participate in Upcoming Life Sciences Investor Conferences
January 05, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
COVID-19
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.